PeptideDB

Moguisteine

CAS No.: 119637-67-1

Moguisteine (BBR-2173) is a new-type peripheral non-narcotic antitussive drug.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Moguisteine (BBR-2173) is a new-type peripheral non-narcotic antitussive drug.
In vitro Moguisteine是一种新型的外周非麻醉性镇咳剂,在多个实验模型中证明了其与codeine一样活跃,能够抑制豚鼠和狗的诱导性咳嗽。它不是通过鸦片受体作用,也不直接影响咳嗽中枢,其作用可能通过与气管支气管树上快速适应型刺激性受体的相互作用来介导。在对照临床试验中,moguisteine被证实安全,并能有效减少急性上呼吸道感染、慢性支气管炎、肺纤维化和恶性肿瘤等呼吸系统疾病相关的咳嗽。
Synonyms 莫吉司坦, BBR-2173
molecular weight 339.41
Molecular formula C16H21NO5S
CAS 119637-67-1
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility DMSO: 63 mg/mL (185.6 mM) Ethanol: 63 mg/mL (185.6 mM) H2O: < 1 mg/mL (insoluble or slightly soluble)
References 1. Gallico L, et al. Br J Pharmacol, 1994, 112(3), 795-800. 2. Gallico L, et al. Eur Respir J, 1996, 9(3), 478-485.